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ABSTRACT
During the last decade the knowledge about the molecular mechanisms of the 
cellular adaption to hypoxia and the function of the “von Hippel Lindau” (VHL) protein 
in renal cell carcinoma (RCC) has increased, but there exists little information about 
the overlap and differences in gene/protein expression of both processes. Therefore 
the aim of this study was to dissect VHL- and hypoxia-regulated alterations in the 
metabolism of human RCC using ome-based strategies. The effect of the VHL- and 
hypoxia-regulated altered gene/protein expression pattern on the cellular metabolism 
was analyzed by determination of glucose uptake, lactate secretion, extracellular 
pH, lactate dehydrogenase activity, amino acid content and ATP levels. By employing 
VHL–/VHL+ RCC cells cultured under normoxic and hypoxic conditions, VHL-dependent, 
HIF-dependent as well as VHL-/HIF-independent alterations in the gene and protein 
expression patterns were identified and further validated in other RCC cell lines. 
The genes/proteins differentially expressed under these distinct conditions were 
mainly involved in the cellular metabolism, which was accompanied by an altered 
metabolism as well as changes in the abundance of amino acids in VHL-deficient 
cells. In conclusion, the study reveals similarities, but also differences in the genes 
and proteins controlled by VHL functionality and hypoxia thereby demonstrating 
differences in the metabolic switch of RCC under these conditions.
INTRODUCTION
Renal cell carcinoma (RCC) represents approxi­
mately 2–3% of all cancers worldwide. It is a 
heterogeneous disease with an increasing incidence and 
more than 100.000 deaths per year [1]. While localized 
RCC can be cured by surgery, inoperable RCC is resistant 
to chemotherapy and radiotherapy and about 15% of 
patients respond to immunotherapy. Angiogenesis plays 
an important role in RCC development and progression 
as evidenced by the molecular genetics of the autosomal 
dominant von Hippel Lindau (VHL) syndrome and 
the clear cell RCC (ccRCC) subtype. Drugs targeting 
angiogenic factors have revolutionized the therapy of 
ccRCC and led to a marked survival benefit in patients 
with metastatic disease [2]. However, RCC patients often 
develop resistances to these drugs.
The ccRCC is often associated with a loss of the 
VHL gene function due to its deletion on chromosome 3p, 
loss of heterozygosity, promoter methylation or missense 
mutations. VHL mutations occur in approximately 50% 
of sporadic ccRCC, which prevent the VHL­mediated 
degradation of the hypoxia-inducible factor (HIF)α under 
normoxic conditions. This is also the case by hypoxia, 
which prevents binding of the prolylhydroxylase (PHD) to 
HIFα, thereby leading to the induction of HIF targets. More 
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than 2% of human genes are directly or indirectly regulated 
by HIF [3]. These HIF targets modulate transcriptional 
regulation, cell proliferation, survival, apoptosis, motility, 
cytoskeletal structure, cell adhesion, angiogenesis and 
cellular metabolism [4]. In ccRCC, HIF1α is often not 
expressed, while HIF2α adopts its function [5]. Lack of 
VHL function or hypoxia cause a metabolic switch to 
aerobic glycolysis [6]. This is associated with a high glucose 
influx, a decreased gluconeogenesis and an increased lactate 
concentration in the tumor microenvironment, which is 
associated with an impaired immune recognition [7, 8] due 
to changes in the activity and function of T cells, NK cells 
and dendritic cells (DC) [9–12].
Generally, loss of VHL function or hypoxia has been 
postulated to cause identical alterations in gene/protein 
expression and function. However, this study identified 
differences in the VHL­ and hypoxia­induced pathways 
by determining the mRNA and protein expression pattern 
of VHL­ RCC cell lines and their VHL transfectants 
in the presence and absence of hypoxia using cDNA 
microarrays, 2DE­based proteomics, and metabolomics. 
Selected differentially expressed genes and proteins were 
further validated and subjected to functional analysis.
RESULTS
Characterization of the different VHL model 
systems
The mRNA and protein expression levels of VHL 
were determined under both normoxic and hypoxic 
conditions in the VHL­ cell lines 786­O, RCC4 and RCC10 
and their VHL transfectants using qPCR (Figure 1A) and 
Western blot analysis (Figure 1B), respectively. Expression 
of VHL protein was only detectable in VHL transfectants 
and did not significantly differ between normoxia and 
hypoxia. Over­expression of VHL led to a degradation 
of HIF2α protein during normoxia and to its stabilization 
under hypoxia (Figure 1B). Subsequently, transcription 
levels of the HIF2α target gene GLUT 1 were reduced by 
2.1 to 5­fold under normoxia in the VHL+ RCC cells when 
compared to VHL­ RCC cells. In contrast, hypoxia caused a 
3.5 to 5.9-fold up-regulation of GLUT1 expression in VHL+ 
RCC cells when compared to normoxia (Figure 1C).
Identification of VHL- and hypoxia-induced 
genes
The gene expression pattern of VHL­ and VHL+ 
786­O cells was determined under normoxic and hypoxic 
conditions. The levels of gene expression significantly 
differed between the cell systems and culture conditions 
used (Table S2). Some genes were down­regulated up 
to approximately 60­fold (NID2), while others were up­
regulated to approximately 25­fold (RAB31) depending 
on the conditions analysed.
The most differentially expressed transcripts with 
n = 1202 and n = 1292, respectively, were found upon 
comparison of VHL+ with VHL­ cells under normoxia and 
hypoxia (Table S3). The overlapping genes (662 genes, 
Figure S1, Table S4) of these groups represent putative 
VHL­regulated genes.
The greatest proportion of differentially expressed 
genes mediated by VHL expression (24%; Figure 2A) 
and hypoxia (28%; Figure 2B) exert a metabolic function. 
Figure 2C summarizes the hierarchical clustering of the 
differentially expressed metabolic genes in VHL-deficient 
vs. VHL­expressing cells under normoxia and/or hypoxia 
(p < 0.05). The number of VHL­independent, hypoxia­
regulated genes (194 regulated cDNAs) was much lower 
(Table S2), but the lowest number was found for putative 
HIF2α–regulated genes (28 genes, Table S4). These 
data indicated distinct VHL­, hypoxia­ as well as HIF­
independent regulated processes.
Identification of VHL- and hypoxia-regulated 
targets
In order to identify differentially expressed proteins 
caused by a distinct VHL status and hypoxic environment, 
2DE­based proteomics of VHL­ and VHL+ 786­O cells 
cultured under normoxia or hypoxia was performed 
leading to 76 differentially expressed proteins identified 
by MALDI-TOF/MS analysis (Table S3, Table S5). These 
included VHL­independent, but hypoxia­dependent 
as well as VHL­dependent and hypoxia­independent 
and HIF2α-dependent targets, respectively. Figure 2D 
shows identified differentially expressed proteins on a 
representative 2­DE gel of VHL­ vs. VHL+ 786­O cells 
during hypoxia. Although the differentially expressed 
proteins were associated with distinct functions, 
approximately 30% of VHL­regulated proteins and 38% of 
hypoxia­regulated proteins belong to metabolic processes 
(Figure 2E, 2F). There exists a significant overlap in 
differentially expressed proteins by comparing VHL­ vs. 
VHL+ 786-O protein profiles to that of 786-O cells under 
normoxic versus hypoxic conditions, whereas only a 
few proteins were found to be differentially expressed in 
normoxic vs. hypoxic 786­O cells (n = 13) and VHL+ 786­
O cells (n = 2), respectively (Table S5).
Impact of VHL- and hypoxia-dependent 
alterations on the cellular metabolism
In order to validate the differentially expressed 
genes and proteins, modulated by VHL, hypoxia or 
a combination of both, qPCR, Western blot analyses 
and enzymatic activity assays of selected targets were 
performed.
The glucose consumption of the VHL­/+ RCC model 
system was investigated via the uptake of fluorescent 
dye labelled glucose. The VHL+ RCC cells showed a 
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Figure 1: Restoration of functional VHL expression in 786-O, RCC4 and RCC10 cells. (A) VHL­ cells were stably transfected 
with a VHL overexpression vector or vector backbone. The bulk cultures were analysed for VHL mRNA expression after 24 h incubation 
during normoxia or hypoxia (1% O2) conditions using qPCR. The data was normalized to β-actin expression and the expression of wild type 
cells incubated under normoxia was set to 1. (B) Western blot analysis of VHL and HIF2α protein in wt 786-O, RCC4, and RCC10 cells 
and their respective transfectants during normoxia and hypoxia. Immunostaining was performed with a VHL- and HIF2α-specific antibody 
as described in the experimental procedures. Equal amount of protein loading was controlled by immunostaining using β-actin-specific 
antibody. A representative result of three independent biological replicates is shown. (C) mRNA expression of HIF2α target gene GLUT1 in 
VHL­ and VHL+ cells during normoxia and hypoxia oxygen conditions was measured by qPCR and normalized to β-actin. The expression 
level of wt RCC cells was set to 1.
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Figure 2: Functional classification of VHL- and hypoxia-dependent regulated genes and proteins. (A and B) The cDNA 
microarray analysis was performed with Trizol-prepared total RNA as described in experimental procedures. For the classification of 
data in biological processes the PANTHER classification system according to gene ontology criteria was employed. The pie chart shows 
representative classifications for (A) VHL+ vs. VHL­ 786­O cells, and (B) wt cells incubated during hypoxia (1% O2) vs. normoxia.  
(C) Hierarchical clustering of “ome”-based data. Using the hierarchical clustering differentially expressed genes associated with metabolic 
function (p <0.05) identified by one way ANOVA among VHL+, VHL­ 786­O under hypoxia or normoxia (top heat map) and hypoxia­ 
vs. normoxia-specific metabolic function related genes independent of VHL status (t test, p < 0.05, bottom heat map) were visualized.  
(D) Identified differentially expressed proteins were marked on a representative 2-DE gel of VHL­ vs. VHL+ 786­O cells during hypoxia.  
(E and F) The pie charts demonstrate the classification of differentially expressed proteins, which were identified by 2DE followed by 
peptide mass fingerprint. The classification of proteins was performed with PANTHER software and is representatively demonstrated for 
E) VHL+ vs. VHL­ 786­O cells and F) wt cells incubated under normoxic and hypoxic (1% O2) conditions.
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statistically significant ≅2­fold reduced glucose uptake 
compared to the VHL-deficient RCC cells (Figure 3A), 
which was accompanied by an altered expression of many 
glycolytic enzymes (Table S6). In addition, extracellular 
flux analysis was performed to assess the ECAR. As shown 
in Figure 3B, VHL expression significantly decreased 
glycolysis and glycolytic activity. A VHL­dependent down­
regulation of pyruvate kinase (PK)M2, γ-enolase (ENO2) 
and triosephosphate isomerase (TPI)1 was detected, 
while ENO2, TPI1 and aldolase (ALDO)A were hypoxia­
dependently up­regulated (Table S6). Over­expression of 
VHL caused a 2­ to 2.5­fold reduction in the expression of 
TPI1 under normoxic conditions in comparison to VHL­
deficient RCC cells, while its expression was enhanced 
2­ to 3.9­fold under hypoxia in the VHL+ RCC cells when 
compared to normoxic conditions (Figure 3C). In VHL­ 786­
O and RCC4 cells, the expression of ALDOA is hypoxia­
dependent 1.7­ to 2­fold up­regulated, while in RCC10 cells 
a 2.5­fold VHL­mediated down­regulation of ALDOA was 
observed, which could be restored by hypoxia (Figure 3D). 
Furthermore, the intracellular ATP levels were up to 67% 
decreased in VHL+ when compared to VHL­ RCC cells 
(Figure 3E).
Association of VHL expression with an induction 
of the citric acid cycle and the mitochondrial 
respiratory chain
To further analyse the VHL status­dependent 
metabolic changes, the tricarboxylic acid cycle (TCA) 
and the mitochondrial respiratory chain activity was 
determined in VHL­/VHL+ model systems. Despite a 
VHL­dependent suppression of glycolysis and ATP 
production, the expression of the enzymes of the TCA 
and, consequently, of the mitochondrial respiratory chain 
were increased (Table S6). Interestingly, the SDHA 
transcription was neither dependent on VHL nor on 
hypoxia (Figure 4A). In contrast, the protein expression 
of SDHA was approximately 2­fold up­regulated in 
VHL+ RCC cells (Figure 4B, 4C). The mitochondrial 
respiration was assessed in VHL­/VHL+ RCC cells using 
the extracellular flux assay. An increase of basal oxygen 
associated with an increased respiration and respiratory 
reserve was found in VHL+ compared to VHL­ RCC cells 
(Figure 4D). This was associated with a 1.5 to 2­fold 
increase of the mitochondrial dehydrogenase activity upon 
VHL overexpression (Figure 4E).
VHL-dependent regulation of lactate secretion 
and pH regulation
Since VHL could regulate the lactate dehydrogenase 
(LDH) expression [18, 19], the intracellular LDH activity of 
the VHL­ and VHL+ cells was determined. When compared 
to VHL­ RCC cells, LDH activity was down­regulated 
between 30% to 66% in VHL transfectants (Figure 5A), 
which was associated with an up to 55% lower extracellular 
lactate concentration (Figure 5B) and an altered pH in the 
cell culture supernatant (Figure 5C). In contrast, hypoxia 
restored the VHL­mediated reduction of LDH activity and 
lactate secretion, which is accompanied by a drop in the 
extracellular pH of the VHL transfectants (Figure 5).
Altered VHL-dependent amino acid content in 
RCC cell lines
In order to investigate whether the amino acid 
metabolism is also altered by the VHL status, the content 
of 20 free amino acids was measured in the 786­O VHL 
model system under normoxic conditions. In comparison 
to VHL-deficient 786-O cells, the overall content of free 
amino acids was reduced about 25% in VHL+ RCC cells, 
with the highest down­regulation of 2.5­fold for serine 
(Figure 6). In contrast, the arginine concentration was not 
altered in the presence or absence of VHL.
DISCUSSION
Major advances have been made in our understanding 
of the molecular mechanisms of cellular adaption to 
hypoxia and the function of VHL. Nevertheless, little 
information exists about the overlap and differences of 
VHL­dependent/independent and hypoxia­dependent 
alterations in gene and protein expression patterns and their 
effects on the cellular metabolism. Therefore, the aim of 
the study was to dissect both the VHL­ and/or hypoxia­
induced pathways, which might lead to the identification 
of candidate biomarkers for disease progression and 
novel therapeutic targets. Using a tandem approach of 
cDNA microarrays and 2­DE­based proteome analyses, 
a large number of differentially expressed genes and/or 
proteins could be detected in VHL+ versus VHL­ RCC 
cells as well as under normoxic and/or hypoxic conditions. 
Despite a high frequency of genes/proteins concordantly 
regulated by loss of VHL function and hypoxia, a number 
of differentially expressed genes/proteins demonstrating a 
VHL­dependent, VHL­independent, hypoxia­dependent, 
and hypoxia­independent regulation, respectively, of 
the gene and protein expression profiles was identified. 
qPCR and/or Western blot validation further confirmed 
the differential gene and protein expression profiles in 
the VHL­ and VHL+ RCC model systems analysed in the 
absence or presence of hypoxia. Reflecting the biology and 
molecular features of RCC, the differentially expressed 
genes/proteins were mainly involved in the cell metabolism 
and were localized in the cytoplasm. In most cases there 
exists a concordant expression of these molecules at the 
mRNA and protein level, although some genes appear to 
be post­transcriptionally controlled, such as SDHA. These 
data are in line with the proteome analysis of primary RCC 
lesions and patient­matched normal kidney epithelium 
demonstrating an altered glycolysis and gluconeogenesis 
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Figure 3: VHL-dependent changes in glucose uptake and glycolysis. (A) 1 × 104 cells/cell line were seeded and the glucose 
uptake was measured by incorporation of fluorescently labelled deoxyglucose (2-NBDG) at absorption and emission wavelengths of 485 
nm and 535 nm, respectively. The fluorescence signal of wild type (wt) cells was set to 1. The figure shows the mean values and standard 
derivations of three independent assays. (B) The extracellular acidification rate of wt, mock- and VHL-transfected 786-O cells is measured 
in response to the indicated substrates and inhibitors. ECAR is predominantly the result of anaerobic glycolysis. ECAR levels upon 
administration of glucose are indicative for basal glycolysis and upon administration of oligomycin for the cells’ glycolytic capacity. A 
representative analysis as well as the mean values for glycolysis and the glycolytic capacity is shown. Bars indicate the standard error 
mean. Abbreviations: p, p­value; *, p < 0.05; **, p < 0.005; ***, p < 0.001. (C and D) Analyses of TPI1 (C) and ALDOA (D) mRNA 
expression are shown. qPCR analyses of wt and VHL­transfected 786­O, RCC4 and RCC10 cells were performed using oligo­dT primed 
cDNA and normalized to β-actin mRNA expression. The expression levels of parental cells were set to 1 and the diagram shows the means 
with S.D. of three biological replicates. (E) ATP levels were measured by the Cell Titer Glo luminescence cell viability assay as described 
in experimental procedures. The VHL­ RCC cells were set to 1.
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[20, 21]. This study here extended these results by analysing 
the VHL and hypoxia dependence or independence 
demonstrating a link between VHL loss and hypoxia, but 
also a distinction between both pathways. This is mediated 
by an altered gene and protein expression pattern, which 
also modulates the tumor microenvironment thereby 
differentially affecting the metabolic switch of RCC.
Heterogeneous, but increased expression of ALDOA 
was found in RCC subtypes when compared to normal 
kidney cortex [22] as well as in the serum of RCC patients 
and have been used for tumor staging [23]. These data 
were extended by demonstrated an up­regulation of 
ALDOA expression associated with hypoxic conditions 
and loss of VHL expression suggesting a link between 
ALDOA, VHL and hypoxia. Thus, ALDOA might 
represent a suitable and potential target irrespective of the 
VHL status and oxygen conditions.
Several reports have demonstrated a direct 
correlation between the loss of VHL expression and 
alterations in the cellular metabolism, leading to an 
altered tumor microenvironment, such as high lactate 
concentrations and low pH value [24]. This was 
Figure 4: Induction of TCA and mitochondrial respiratory chain through VHL overexpression. (A) The transcription 
level of SDHA was determined using oligo-dT primed cDNA and specific primer via qPCR. Expression of wt cells was set to 1. (B) 50 μg 
protein/cell line was separated by 10% SDS­PAGE, transferred onto a nitrocellulose membrane before immunostaining was performed with 
a SDHA-specific antibody as described in experimental procedures. Equal protein loading was controlled by subsequent immunostaining 
using an anti-β-actin-specific antibody. A representative result of three independent biological replicates is shown. (C) Densitometric 
analysis of SDHA expression in VHL­ and VHL+ 786­O, RCC4 and RCC10 cells incubated during normoxia and hypoxia (1% O2) is 
shown. Areas of immunoblot signals were integrated using AIDA image analyser software and normalized to β-actin. The graphic showed 
the means and S.D. of three independent experiments. (D) The baseline oxygen consumption rate (OCR) was measured by an XFe96 flux 
analyzer in wt, mock­, and VHL­transfected 786­O cells. OCR is an indicator of mitochondrial respiration. Respiration (OCR) is measured 
under basal conditions and in response to the indicated substances. Changes after application of the uncoupling agent FCCP are indicative 
for the respiratory reserve. A representative analysis as well as the mean values for basal respiration and the respiratory reserve is shown. 
Bars indicate the standard error mean. Abbreviations: p, p­value; ***, p < 0.001. (E) 5 × 103 cells/well were seeded in triplicates in 96­
well plates and incubated for 72 h at 37°C and 5% CO2 during normoxia and hypoxia. The activity of mitochondrial dehydrogenases was 
measured trough the turnover of the tetrazolium salt XTT to formazan by the OD of 490 nm.
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Figure 5: VHL-dependent alterations of lactate dehydrogenase activity, lactate secretion and extracellular pH as a 
function of oxygen tension. Five × 103 VHL–/VHL+ cells were seeded in triplicate in 96­well plates and incubated for 48 h under both 
normoxic and hypoxic conditions. Shown are the means and standard derivations of three independent assays (A) The intracellular lactate 
dehydrogenase activity was determined by the CytoTox96 Non­Radioactive Cytotoxicity Assay (Promega). The LDH activity of wt RCC 
cells was set to 1. (B) Extracellular lactate levels in the cell culture supernatants of VHL­ and VHL+ RCC cells under both normoxic and 
hypoxic conditions. (C) Changes in the pH value of supernatants in relation to the respective VHL-deficient RCC cell line under normoxia.
Figure 6: Intracellular free amino acid levels of wt, VHL+ and VHL- 786-O cells. Amino acid concentrations are expressed 
as ratios relative to the wt, which was set to one. A one-way ANOVA followed by Tukey post hoc test was performed to test for significant 
differences (*p ≤ 0.05, **p ≤ 0.01).
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also confirmed in this study by reversible hypoxia- 
and VHL loss­mediated changes of the intracellular 
lactate dehydrogenase levels, extracellular lactate 
concentrations and extracellular pH, as well as the 
differential expression of genes/proteins involved 
in changes of the tumor microenvironment. These 
alterations could lead to an immune suppressive tumor 
microenvironment [25] although a correlation of the 
VHL status with the immune cell infiltration has not yet 
been determined in detail.
Metabolome analysis demonstrated an altered 
metabolite and amino acid content in VHL­ vs. VHL+ cells 
(Figure S2), thus supporting their distinct metabolism and 
was further strengthened by recent work of Gameiro and 
co­authors describing reduced intracellular citrate levels in 
VHL mutant versus VHL wt RCC cells due to the presence 
of HIF thereby linking VHL and hypoxia and sensitizing 
VHL-deficient cells to glutamine deprivation [26]. 
Citrate levels could be restored by silencing PDK­1 and 
ACLY, which was accompanied by suppression of RCC. 
Furthermore, HIF rendered VHL-deficient cells sensitive 
to glutamine deprivation in vitro, while systemic treatment 
with glutaminase inhibitors suppressed the in vitro and in 
vivo growth of RCC cells.
MATERIALS AND METHODS
Cell lines and hypoxia incubation
The RCC cell lines RCC4 and RCC4 VHL 
were obtained from Health Protection Agency Culture 
Collections (Salisbury, UK). The RCC cell lines 786-O 
and RCC10, and their respective stable VHL transfectants 
were kindly provided by Prof. Wiesener (Erlangen) and 
were authenticated by DNA profiling. All cell lines were 
maintained in DMEM supplemented with 10% fetal 
calf serum (Gibco), 2 mM glutamine (Biochrom AG), 1 
mM pyruvate (Gibco), 100 U/mL penicillin and 100 μg/
mL streptomycin (PAA). Cells were cultivated for 24 
to 72 h either under normal oxygen conditions or at 1% 
oxygen (hypoxia incubator, Binder) at 37°C and 5% CO2. 
All experiments were carried out during the logarithmic 
growth phase of the cells.
Microarray analysis
Total RNA was extracted from 3 × 106 cells 
using Trizol reagent (Invitrogen), reverse transcribed 
and amplified with the WT expression kit (Invitrogen) 
according to the manufacturer’s manual. Fragmented 
cDNA was end­labeled using the Affymetrix terminal 
labeling kit and hybridized onto Human GeneChip 1.0 ST 
arrays (Affymetrix). The chips were stained and washed 
following standard procedure and scanned on a GeneChip 
Scanner 3000 7G (Affymetrix).
Two-dimensional gel electrophoresis
Protein was isolated from 5 × 107 VHL­/VHL+ 786­
O cells incubated for 48 h under normoxic or hypoxic 
conditions. 550 μg/protein lysate were loaded onto IPG 
strips (pH 3–10, non­linear, Amersham Biosciences) 
followed by an isoelectric focusing and second­dimension 
SDS­PAGE separation (13%) and staining with colloidal 
Coomassie as described [13]. The gels were analyzed 
using the Delta2D software package (Decodon). Proteins 
found to be at least two-fold regulated (factor ≥ 2.0 or 
≤ 0.50; p ≤ 0.05) were subjected to mass spectrometric 
identification. The two-dimensional gel electrophoresis 
was carried out in three independent experiments using 
five gels for each condition.
In-gel digestion and mass spectrometric analysis
Differentially regulated protein spots were excised 
from the gels using the Spothunter (Herolab), destained 
with 50% acetonitrile (v/v) over night and subjected to 
in-gel digestion with 8 μg/mL porcine trypsin (Promega). 
Tryptic digests were subjected to MALDI-TOF mass 
spectrometry (Ultraflex, Bruker). Protein identification 
was performed as previously described [13].
RNA isolation and real time quantitative PCR
Total cellular RNA was isolated using the 
NucleoSpin RNA II kit (Macherey & Nagel). Two μg 
of total RNA were reverse transcribed into cDNA using 
the Revert H Minus First Strand cDNA synthesis kit 
(Fermentas) and oligo(dT)18 primer according to the 
manufacturer’s instructions. Comparative quantification 
of gene expression was performed as previously described 
[14]. The target-specific primers used for qPCR are listed 
in the Supplementary Table S1.
Western blot analysis
Cells were harvested as previously described [13] 
and protein isolated according to Laemmli [15]. Fifty 
μg protein/lane were subjected to Western blot analysis 
as recently described [13]. Membranes were incubated 
over night at 4°C with the primary monoclonal antibodies 
(mAb) directed against succinate dehydrogenase complex 
subunit A (SDHA; Cell Signaling), HIF2α (Novus) 
and β-actin (Sigma-Aldrich), followed by incubation 
for 1 h with horseradish peroxidase­linked secondary 
antibody and developed using the ECL method. 
Chemoluminescence signals were detected using a CCD 
camera (LAS3000, Raytest). For quantification of the 
SDHA protein expression the respective area of the signal 
was integrated using an AIDA image analyser (Raytest) 
and subsequently normalized to β-actin.
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Measurement of lactate and mitochondrial 
dehydrogenase activity
5 × 103 VHL­/VHL+ cells were seeded in tripli­
cates in 96­well plates and incubated for 48 h under 
normoxic or hypoxic conditions. The intracellular 
lactate dehydrogenase activity was determined using 
the CytoTox96 Non­Radioactive Cytotoxicity Assay 
(Promega) according to the manufacturer’s instructions. 
Mitochondrial dehydrogenase activity was measured 
by the conversion of the monotetrazolium salt XTT to 
formazan as previously described [16]. The experiments 
were carried out in three independent assays and the 
normalization was performed against the parental cell line.
Determination of lactate concentration and 
extracellular pH
Lactate concentrations were measured using 
the lactate detection kit (Sigma) according to the 
manufacturer’s instructions using supernatants of VHL­ 
and VHL+ cells incubated for 48 h under normoxic and 
hypoxic conditions. In parallel, the extracellular pH was 
determined in the same supernatants used using a digital 
pH meter (p525, WTW). All experiments were carried out 
in three independent assays and the results are represented 
as the mean value of assays.
Measurement of intracellular ATP and glucose 
uptake
For determination of the intracellular ATP content 
5 × 103 cells were seeded in 96­well plates and incubated 
for 24 h under normoxia or hypoxia. The intracellular 
ATP levels were determined using the Cell Titer Glo 
luminescence cell viability assay (Promega) according 
to the manufacturer’s instructions. Luminescence 
was measured using the Lumat LB 9507 luminometer 
(Berthold Technologies). Values were normalized to wild 
type cells cultured under normoxic conditions.
The glucose uptake was measured with fluorescence 
labelled 2­deoxy­2­[(7­nitro­2, 1, 3­benzoxadiazol­4­yl)
amino]­D­glucose (2­NBDG, Cayman Biochemical). 
Briefly, 1 × 104 cells were cultured for 24 h in 96­well 
black/clear tissue culture imaging plates (BD). Cells were 
washed twice with PBS, treated with 0.1 mM 2-NBDG in 
50 μL PBS for 20 min and washed again. The fluorescence 
signal was determined using a Tecan Infinite M200 
fluorescence reader (absorption 485 nm, emission 535 nm).
Extracellular flux assay
2.5 × 105 cells/well were seeded in 96XF micro plate 
(Seahorse Bioscience) and incubated over night at 37°C 
and 5% CO2. One hour prior to measurement with the 
XF96e Extracellular Flux Analyzer (Seahorse Bioscience) 
cells were incubated at 37°C in a CO2­free atmosphere. 
First, the basal oxygen consumption rate (OCR) as 
indicator for mitochondrial respiration and extracellular 
acidification rate (ECAR) as indicator for glycolysis were 
detected. Next, OCR and ECAR were determined after the 
addition of 1 mM oligomycin, 2.5 mM FCCP (Carbonyl 
cyanide-p-trifluoromethoxy-phenylhydrazone) and a 
combination of 3 mM antimycin and 3 mM rotenone (XF 
Cell Mito Stress Test Kit, Seahorse Bioscience) as well 
as 10 mM glucose, 1 mM oligomycin and 100 mM 2-DG 
(XF Cell Glyco Stress Test Kit, Seahorse Bioscience). 
Experiments were performed in octaplicates.
Amino acid analysis
2.5 × 106 cells were seeded in a 6­well plate for 
24 h before the supernatant was collected. The cells 
were washed twice with PBS, scraped in ice­cold 80% 
aqueous methanol and directly frozen at –80°C until 
use. The sample was centrifuged at 4°C and 5.725 × g 
for 5 min and the extract was collected. The protein pellet 
was then washed twice with 80% aqueous methanol, 
the extracts were combined and dried in a vacuum 
evaporator (CombiDancer, Hettich AG). The residue was 
reconstituted in 100 μL water. Amino acid analysis was 
performed by HPLC-ESI-MS/MS using 10 μL cell extract 
following a propyl chloroformate derivatization protocol 
as recently described [17].
Statistical analysis
Microarray: Data analyses were performed using 
Partek Genomic Suite (Partek) software after Robust 
Multichip Average (RMA) normalization. Differentially 
expressed genes were defined by one-way ANOVA with 
a p value < 0.005 and for included metabolic genes of 
hierarchical clustering p < 0.05.
qPCR and metabolic assays: Statistical analysis 
was performed with one­way ANOVA followed by 
Tukey post hoc test or unpaired Student`s t test. 
Significance was accepted if p values were ≤ 0.05 (*p ≤ 
0.05, **p ≤ 0.01, ***p ≤ 0.001). Data were expressed as 
the mean ± S.D.
Data integration and network analysis
Differentially expressed genes were further fun­
ctionally analyzed using Ingenuity Pathway Analysis 
(IPA, Ingenuity) and Gene Ontology enrichment analysis 
integrated in the Partek software.
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Abbreviations
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renal cell carcinoma, ALDOA; aldolase A, AKR1B1; 
aldose reductase, DMEM; Dulbecco’s Modified Eagle’s 
Medium, ECAR; extracellular acidification rate, ECL; 
electrochemiluminescence, ECHS1; enoyl­CoA hydratase 
short chain 1, ENO; enolase, FCS; fetal calf serum, GLUT; 
glucose transporter, HIF; hypoxia inducible factor; HRE; 
hypoxia responsible element, LDH; lactate dehydrogenase, 
MALDI-TOF; matrix-assisted laser desorption/ionization 
time-of-flight, MAPK; mitogen-activated protein kinase, 
MCT; monocarboxylate transporter, OCR; oxygen 
consumption rate, p; p­value, PBS; phosphate­buffered 
saline, PKM; pyruvate kinase, RCC; renal cell carcinoma, 
SDH; succinate dehydrogenasem, SDHA; succinate 
dehydrogenase complex subunit A, TCA; tricarboxylic 
acid cycle, TPI; triose­phosphate isomerase, VHL; von 
Hippel­Lindau Wt, wild type.
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